Liminatus Pharma Surges Over 5% After Announcing $500M BNB Investment Strategy
View all comments(0)
TradingKey – On Monday, July 28, Nasdaq-listed Liminatus Pharma Inc. (LIMN) jumped 5.28% in pre-market trading after unveiling plans to launch a dedicated crypto subsidiary focused on Binance Coin (BNB).

Liminatus Pharma Stock Chart – Source: Google
Liminatus, a preclinical-stage cancer immunotherapy company, announced it will form a new subsidiary called “American BNB Strategy” to manage and invest in BNB, the native token of the Binance ecosystem.
- The company aims to raise up to $500 million, deploying funds in phased investments targeting long-term BNB accumulation
- This move positions Liminatus alongside other corporate BNB holders like Nano Labs (NA), which currently holds 128,000 BNB
Coincidentally, the price of BNB soared above $850 today, setting a new record high. In the past 24 hours, BNB rose by more than 6%, reaching a high of $859 and temporarily reported at $849.

BNB price chart (1 hour), source: TradingView
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
The Week Ahead: US Midterm Elections and October Nonfarm Payrolls Arrive as Earnings From Apple, Palantir, AMD Take Center Stage

Apple Stock Forecast: AAPL Tests $352.04 Before Monday's Earnings as Memory Costs Meet iPhone Duo Demand

World's Largest Companies by Market Cap (October 2026): Apple Overtakes Nvidia as AI Return Doubts Hit Tech Stocks

Nasdaq Drops 2.86% in Biggest Decline Since June as Investors Sell AI Stocks; Philly Semi Falls Over 7%, Intel Plunges 28%

ModelBest and OpenBMB Open-Source MiniCPM-OCR Series, Delivering High-Performance Document Parsing and AI-Powered Quality Control






Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.